MedTrace Logo

Burn Mortality Prediction Scores

NCT07689890 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1082

Last updated 2026-07-08

No results posted yet for this study

Summary

This retrospective observational cohort study evaluates hospitalized burn admissions treated at the Burn Center of Gaziantep City Hospital between October 2023 and February 2026. The study aims to compare the ability of three burn severity scoring systems, the Abbreviated Burn Severity Index (ABSI), Revised Baux score, and modified Ryan score, to predict in-hospital mortality.

Electronic medical records were reviewed for demographic characteristics, burn-related variables, inhalation injury, burn depth, intensive care admission, mechanical ventilation, sepsis, surgical procedures, length of hospital stay, and survival status at hospital discharge. The primary outcome is in-hospital mortality. The predictive performance of the scoring systems will be evaluated using receiver operating characteristic analysis and logistic regression.

Conditions

  • Burn Injury
  • In-Hospital Mortality

Interventions

OTHER

Retrospective Prognostic Score Assessment

ABSI, Revised Baux score, and modified Ryan score were retrospectively calculated using routinely collected electronic medical record data from hospitalized burn admissions. These scores were evaluated for their ability to predict in-hospital mortality. No drug, device, procedure, or treatment intervention was assigned by the study protocol.

Sponsors & Collaborators

  • Gaziantep City Hospital

    lead OTHER

Principal Investigators

  • Bekir Suat Kurkcuoglu · Gaziantep City Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-07
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07689890 on ClinicalTrials.gov